Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
Titel:
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
Auteur:
Herrera, Alex F Zain, Jasmine Savage, Kerry J Feldman, Tatyana Brammer, Jonathan E Chen, Lu Puverel, Sandrine Popplewell, Leslie Budde, Lihua Elizabeth Mei, Matthew Hosing, Chitra Nair, Ranjit Leslie, Lori Daniels, Shari Peters, Lacolle Forman, Stephen Rosen, Steven Kwak, Larry Iyer, Swaminathan P